Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Size: px
Start display at page:

Download "Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes."

Transcription

1 Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical decision making by describing a range of generally acceptable intervention and outcomes. The guidelines attempt to define practices that meet the needs of most patients under most circumstances. However, the ultimate judgment must be made based on circumstances that are relevant to that patient and treatment may be modified according to the individual patients needs.

2

3 PACU Lumbar Fusion Clinical Pathway PAIN MANAGEMENT / COMFORT PAIN GUIDE Preoperative Medications: 1) Acetaminophen Dose: 1000 mg PO Contraindications: severe liver dysfunction, allergy, use within previous 6 hours 2) Pregabalin OR Gabapentin OR Home Dose if taking Mscontin or Oxycontin Doses: Please consider contributions from other sedating agents or medical comorbidities and modify dose accordingly. i. Pregabalin: 150 mg if < 70 yr old and > 70 kg 75 mg if > 70 old or < 70 kg ii. Gabapentin: 600 mg if < 70 yr old and > 70 kg 300 mg if > 70 yr old or < 70 kg Contraindications: renal dysfunction (GFR < 30), allergy Chronic users should receive their scheduled dose in preop holding if they did not take it prior to coming to the hospital. 3) Oxycontin Dose: 10 mg if not taking long-acting narcotic chronically Patients taking MScontin, oxycontin, methadone should receive their regularly scheduled dose instead. Intraoperative Analgesia Management suggestions: 1) Opioids a. Fentanyl: minimize use b. Hydromorphone/Morphine/Methadone: Use intraoperatively as needed. 2) Ketamine: this is useful to spare opioids and to reduce risk of hyperalgesia. It is useful in highly opioid tolerant patients and in neuromonitoring cases. Bolus dosing: mg/kg after induction Drip: mg/kg/hr Side effect profile is minimal using these dosing strategies 3) Dexmedetomidine: This is very effective in highly opioid tolerant patients. Can cause significant sedation in higher doses. Can cause bradycardia and hypotension, dry mucous membranes. Dose: mcg/kg/hr (IBW) Bolus (use great caution) 5-10 mcg q 5 minutes up to 1 mcg/kg IBW 4) Anti-Infectives: Antibiotics are per ID recommendations. These recommendations are posted in the OR or available on the portal. 4) Celecoxib Dose: 400 mg x 1 Contraindications: Significant renal dysfunction, platelet dysfunction Severe CAD Allergy (remember this drug may be problematic in patients with sulfa allergy)

4 Lumbar Fusion Pain Pathway Lumbar Fusion Pain Pathway Excludes Dr. Glazer patients Generalized Pain Pathway Descriptions: A Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day B Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day C Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Epidural? Consult APS (3PAIN) Tolerates PO? Is this a CPS patient? Contact CPS 3OUCH Patient taking < 60 mg morphine/day Pathway A Opioid Naive Is there adequate analgesia? Patient taking > 60 mg morphine/day Pathway B Opioid tolerant Follow CPS plan Prepare discharge plan including: 1) Weaning from opioids 2) PRN-(or) as needed Suboxone, subutex, Naltrexone? CPS/POP Consult required Pathway C IV pathway (least preferred) Patient should be changed to PO ASAP

5 Pathway A: Opiate naïve or uses < 60 mg morphine equivalent/day (see table) B Drug Initial dose Frequency Adjustment options Acetaminophen mg 500 mg Q 6-8 hours Preferred Oxycodone 5-10 mg PO Q 4 hours mg Q 4 hours Hydromorphone 2-4 mg PO Q 4 hours 4-6 mg, can give Q 3hours Morphine PO (MSIR) Anticonvulsants Muscle relaxants 15mg PO Q 4 hours ne, contact APS Start with low dose Start with low dose See list below See list below Oxycontin 2 10 mg PO Contact APS MSContin 2 15 mg PO, Contact APS Ketamine drip mg/kg/hr Infusion Contact APS (with APS consult only) Celecoxib mg PO Once/day 200 mg BID 3 x 24 hr Restrict use 1. Acetaminophen: decrease dose or avoid in patients with liver dysfunction. 2. Consider omitting in opioid naïve patients who are not taking any opioids at baseline. 3. Single preoperative celecoxib dose OK. If celecoxib or ketorolac are needed postop, attending surgeon approval is required. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea o Cognitive dysfunction o Over 70 years old

6 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or Flexeril CPS only. Continue drug if patient has (cyclobenzaprine) been stabilized on one of these drugs 5 mg PO 10 mg preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop α-2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, Hydromorphone 4 mg 20 mg buprenorphine, Naltrexone IM or for any patient taking greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg

7 Pathway B: Opiate tolerant patients (> 60 mg morphine equivalents/day) C. a) These patients should have a preoperative POP consult with CPS. b) If patients do not have a CPS or POP consult, please use the suggested doses listed below. Consider APS consult. c) Please use IV breakthrough narcotics as listed for opiate-naïve patients Drug Initial dose Frequency Adjustment options Oxycodone mg PO Q 4 hours 20 mg Q 4 hours Hydromorphone 4-6 mg PO Q 4 hours 4-8 mg, may give Q 3hours Morphine PO (MSIR) 15-30mg PO Q 4 hours 30 mg Q 4 hours Acetaminophen 1000 mg PO 500 mg Q 6-8 hours 1 Anticonvulsants 4 Muscle relaxant Oxycontin MSContin Clonidine (APS consult unless patient taking preoperatively) Ketamine drip (APS consult required) Start with low dose. (see note 4 below) Start with low dose. 10 mg (or preoperative dose) 15 mg (or preoperative dose) 0.1 mg patch +/- tablet Q 8-12 hours Q 7 days See list below See list below mg/kg/hr Infusion Contact APS 2 Use APS/CPS recommended dose Use APS/CPS recommended dose Contact APS for any dosing adjustments Celecoxib mg PO Once/day After initial dose: 200 mg BID 3 Preferred Restrict use 1. Acetaminophen: decrease dose or avoid in patients with liver dysfunction. 2. APS will manage ketamine infusions in conjunction with CPS. 3. Single preoperative dose Celecoxib permitted. If celecoxib or ketorolac are needed postop, attending surgeon approval is required. 4. Patients who have been stabilized on anticonvulsants should continue on preoperative dose. Consider increasing dose for inadequate analgesia if patients are having pain and are not overly sedated. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea, o Cognitive dysfunction o Over 70 years old.

8 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or Flexeril CPS only. Continue drug if patient has (cyclobenzaprine) been stabilized on one of these drugs 5 mg PO 10 mg preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop α-2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, Hydromorphone 4 mg 20 mg buprenorphine, Naltrexone IM or for any patient taking greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg

9 Pathway C: IV Pathway Primary use of IV analgesia should be reserved for patients who are: 1) Strictly NPO 2) Intolerant of PO analgesia due to N/V or other gastrointestinal concerns. Avoid mixing IV and PO pathways without consultation from APS or CPS. Drug Dose Frequency Adjustments PCA hydromorphone mg Q 6 min Up to 0.36 mg Q 6 min. Preferred PCA morphine mg Q 6 min Up to 2 mg Q 6 min. Acetaminophen 1000 mg IV Q 6 hours 500 mg Q 6 hours or 1000 mg. Lorazepam mg IV/IM Q 6-8 hours mg IV Q 6-8 hours 1 Diazepam 5 mg IV/IM Q 6-8 hours 10 mg IV Q 6-8 hours 1 Ketorolac mg Q 6hr x 48 hr 1. Respiratory depression risk is high when combined with opioids. This is increased in patients with OSA, > 70 years old, those with cognitive or neurological dysfunction. Diazepam had active metabolites that result in increased sedative effects over time. 2. Must have attending surgeon approval before administering NSAIDS. Restrict use Contact APS for management of pain in post-operative patients with inadequate analgesia despite use of pathway medications. The number on the VAS may not reflect clinical picture. Consider baseline pain score. Contact CPS for management of patients with a POP consult. If you are not sure, call APS. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea o Cognitive dysfunction o Over 70 years old

10 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or Flexeril CPS only. Continue drug if patient has (cyclobenzaprine) been stabilized on one of these drugs 5 mg PO 10 mg preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop α-2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, Hydromorphone 4 mg 20 mg buprenorphine, Naltrexone IM or for any patient taking greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg

11 Lumbar Fusion Clinical Pathway 2015 What: Who: Why: Clinical Pathway Practice Changes Lumbar Fusion Patients Clinical Pathway Education related to Pain Management, Mobility, Patient Education, and Discharge Planning Goals: 1. Improved Pain Management with Early Utilization of Oral Pain Medications 2. Increase Early Mobilization to Prevent or Decrease Post-Operative Risk Factors. (ie. Ileus, Blood Clots, and Infections) 3. Improve Documentation of Patient Progress related to pain and mobility. 4. Enhanced Continuous Patient Education and Discharge Planning 5. Decrease the Length of Stay in the Patients S/P Lumbar Fusion Generalized Pain Pathway Descriptions: A Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day B Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day C Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Important Practice Changes for the Lumbar Fusion Pathway Documentation Clinical Pathway in Patient s Chart Pain Management Actual designation of a Pain Pathway A, B, C, or CPS Consult Use of pre-op oral pain medications: Gabapentin, Tylenol, Oxycontin/MS Contin use of PCA s post-op: Utilizing oral pain medications immediately post op, along with IV pain medications for breakthrough pain instead of PCA: Overview of doses OK to use full dose Explain adjustment options Strict Q4H pain check-ins Important to stay ahead of the pain Set appropriate expectations with the patient (language?) Wake patients at night Bracing If a brace is indicated, use of prefabricated braces are issued to patients by POD 0/POD 1. (Exception of Dr. Glazer s patients) Activity Early Mobilization by Nursing. PT Eval and Treatment: POD#2 and POD#4. Other Use of standing PO Bowel Medications and addition of SC Methylnaltrexone POD 1 Use of PO Flomax POD #1 in men ages 55 years of age or older Starting SC Heparin POD #1, unless patient is ambulating STANDARDIZED PATHWAY VALUE Better Pain Management Increased Mobility, Decreased Risk Factors

12 Lumbar Fusion Pain Pathway Lumbar Fusion Pain Pathway Excludes Dr. Glazer patients Generalized Pain Pathway Descriptions: A Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day B Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day C Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Epidural? Consult APS (3PAIN) Tolerates PO? Is this a CPS patient? Contact CPS 3OUCH Patient taking < 60 mg morphine/day Pathway A Opioid Naive Is there adequate analgesia? Patient taking > 60 mg morphine/day Pathway B Opioid tolerant Follow CPS plan Prepare discharge plan including: 1) Weaning from opioids 2) PRN-(or) as needed Suboxone, subutex, Naltrexone? CPS/POP Consult required Pathway C IV pathway (least preferred) Patient should be changed to PO ASAP

WITHDRAWAL OF ANALGESIA AND SEDATION

WITHDRAWAL OF ANALGESIA AND SEDATION WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses

More information

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,

More information

Lidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD

Lidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD Lidocaine Infusion for Perioperative Pain Management Marley Linder, PharmD Matt McEvoy, MD Perioperative Surgical Home: PCS Shared Goals Improved Outcomes (pain, PONV, LOS, SSI) Improve Throughput (Clinic

More information

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC Acute Pain Management in the Opioid Dependent Patient Maripat Welz-Bosna MSN, CRNP-BC Relieving Pain in America (IOM) More then 116 Million Americans have pain the persists for weeks to years $560-635

More information

IACUC Guideline LARGE ANIMAL FORMULARY

IACUC Guideline LARGE ANIMAL FORMULARY The intention behind the development of a University of Pennsylvania IACUC-endorsed drug formulary for the larger species used in biomedical research was to provide guidance for anesthetic and analgesic

More information

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist Case Studies: Acute pain management in patients with opioid addiction Shannon Levesque, PharmD Clinical Pharmacist Disclosure I have no financial relationships with industry to disclose Objectives Misconceptions

More information

MUSC Opioid Analgesic Comparison Chart

MUSC Opioid Analgesic Comparison Chart MUSC Opioid Analgesic Comparison Chart Approved by the Pharmacy and Therapeutics Committee (February 2006, November 2009, March 2010, December 2011) Prepared by the MUSC Department of Pharmacy Services

More information

Review of Pharmacological Pain Management

Review of Pharmacological Pain Management Review of Pharmacological Pain Management CHAMP Activities are possible with generous support from The Atlantic Philanthropies and The John A. Hartford Foundation The WHO Pain Ladder The World Health Organization

More information

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less)

AGS. PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less) AGS PAIN MANAGEMENT FOR THE SURGICAL RESIDENT (in 30 min or less) THE AMERICAN GERIATRICS SOCIETY Geriatrics Health Professionals. Leading change. Improving care for older adults. CASE PRESENTATION 46-year-old

More information

Nurses Self Paced Learning Module on Pain Management

Nurses Self Paced Learning Module on Pain Management Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa

More information

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline

More information

Opioid Analgesics. Week 19

Opioid Analgesics. Week 19 Opioid Analgesics Week 19 Analgesic Vocabulary Analgesia Narcotic Opiate Opioid Agonist Antagonist Narcotic Analgesics Controlled substances Opioid analgesics derived from poppy Opiates include morphine,

More information

Targeting patients for use of dexmedetomidine

Targeting patients for use of dexmedetomidine Targeting patients for use of dexmedetomidine H a n n a h W u n s c h, M D M S c H e r b e r t I r v i n g A s s i s t a n t P r o f e s s o r o f A n e s t h e s i o l o g y & E p i d e m i o l o g y

More information

Pain Management in Palliative and Hospice Care

Pain Management in Palliative and Hospice Care Pain Management in Palliative and Hospice Care Donna Butler, MSN, ANP-BC, OCN, ACHPN, FAAPM Current Status of Pain Cancer patients at EOL- 54% have pain AIDS with prognosis < 6mons- intense pain Less research

More information

Management of Patients with Narcotic Bowel Syndrome(1)

Management of Patients with Narcotic Bowel Syndrome(1) Management of Patients with Narcotic Bowel Syndrome(1) Ademola Aderoju MD, Jacob Kurlander MD, Christina Davis, Patrick Barrett MD, Douglas A. Drossman MD Patients on chronic narcotics who have been diagnosed

More information

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose OPIOID CONVERSIONS 1. Converting Short acting Long Acting (IR SR) when pain is well controlled *Use for : CHRONIC pain Pts on scheduled IR opioids pain that recurs before the next dose PP: Can use equianalgesic

More information

New England Pediatric Sickle Cell Consortium

New England Pediatric Sickle Cell Consortium New England Pediatric Sickle Cell Consortium Management of Acute Pain in Pediatric Patients with Sickle Cell Disease (Vaso-Occlusive Episodes) Disclaimer Statement: Hospital clinical pathways are designed

More information

OPIOIDS CONVERSION GUIDELINES 2007

OPIOIDS CONVERSION GUIDELINES 2007 Opioid analgesics vary in potency, side effect and pharmacokinetic profile. Therefore the Opioid Conversion Guidelines has been developed to assist when changing opioid drug therapy. When opioid rotating

More information

Objectives. Important Principles

Objectives. Important Principles Management of the Intubated Patient Christopher J. Edwards, PharmD, BCPS Clinical Pharmacist - Emergency Medicine March 19 th, 2013 REPS EC SAG 2 Objectives Describe the rationale for post intubation analgesia

More information

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics POST-TEST University of Wisconsin Hospital & Clinics True/False/Don't Know - Circle the correct answer T F D 1. Changes in vital signs are reliable indicators of pain severity. T F D 2. Because of an underdeveloped

More information

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain

1. Which of the following would NOT be an appropriate choice for postoperative pain. C. Oral oxycodone 5 mg po every 4 to 6 hours as needed for pain Pain Management 1 Chapter 34. Pain Management, Self-Assessment Questions 1. Which of the following would NOT be an appropriate choice for postoperative pain management in a patient dependent on opioids?

More information

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering

More information

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010 Pain Control Aims General principles of pain control Basic pharmacokinetics Case history demo Opioids renal failure John Welsh 8/4/2010 Pain Control Morphine is gold standard treatment for moderate to

More information

Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia

Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia Chemical Restraint Protocols Trap, Neuter, Release Anesthetic

More information

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida Management of severe pain in small animals continues to be a challenge

More information

MEDICATION ABUSE IN OLDER ADULTS

MEDICATION ABUSE IN OLDER ADULTS MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern

More information

Abstral Prescriber and Pharmacist Guide

Abstral Prescriber and Pharmacist Guide Abstral Prescriber and Pharmacist Guide fentanyl citrate sublingual tablets Introduction The Abstral Prescriber and Pharmacist Guide is designed to support healthcare professionals in the diagnosis of

More information

NEONATAL ABSTINENCE SYNDROME. Osama Naga, M.D. PGY2

NEONATAL ABSTINENCE SYNDROME. Osama Naga, M.D. PGY2 NEONATAL ABSTINENCE SYNDROME Osama Naga, M.D. PGY2 Objective: Describe the common causes of NAS Clinical Presentation Diagnosis Identify the different scoring system for pharmacologic therapy Minimize

More information

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin

Cancer Pain Role Model Program Case Studies and Faculty Guides. Wisconsin Cancer Pain Initiative Madison, Wisconsin Cancer Pain Role Model Program Case Studies and Faculty Guides Wisconsin Cancer Pain Initiative Madison, Wisconsin Developed by: David Weissman, MD June L. Dahl, PhD WISCONSIN CANCER PAIN INITIATIVE CANCER

More information

Medications for chronic pain

Medications for chronic pain Medications for chronic pain When it comes to treating chronic pain with medications, there are many to choose from. Different types of pain medications are used for different pain conditions. You may

More information

OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow

OPIOID NEUROTOXICITY - BACK TO BASICS. Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OPIOID NEUROTOXICITY - BACK TO BASICS Dr. Suzy Pinnick (PGY-3): Palliative Medicine Fellow OBJECTIVES Some Cases Definitions: Including what is opioid neurotoxicity A bit of biochemistry What patients

More information

PAIN MANAGEMENT Alison Deputy, LVT

PAIN MANAGEMENT Alison Deputy, LVT VCA Veterinary Specialty Center of Seattle Continuing Education Seminar 2011 PAIN MANAGEMENT Alison Deputy, LVT The process in which the brain receives, interprets and reacts to pain is extremely complicated

More information

CORONER S REPORT REPORT

CORONER S REPORT REPORT CORONER S REPORT 26 THE CORONER HAS RECOMMENDED THAT THE ONTARIO COLLEGE OF PHARMACISTS EDUCATE CLINICIANS ON THE DEFINITION OF OPIOID TOLERANCE, AND REVIEW THE PATIENT CONDITIONS AND COMORBIDITIES THAT

More information

Passionate concerns about welfare and ethics have created an environment where discussions about

Passionate concerns about welfare and ethics have created an environment where discussions about M e d i c a t i o n s P A I N M A N A G E M E N T Lysa Pam Posner, DVM, Diplomate ACVA North Carolina State University Analgesia for Declaw Patients Onychectomy in cats is controversial both within and

More information

IACUC Guideline RODENT ANESTHESIA & ANALGESIA FORMULARY

IACUC Guideline RODENT ANESTHESIA & ANALGESIA FORMULARY Background This guideline is designed to provide a single source of information for investigators that use rodents models of biomedical disease and discovery. The following tables reference contemporary

More information

Pain Medication Taper Regimen Time frame to taper off 30-60 days

Pain Medication Taper Regimen Time frame to taper off 30-60 days Pain Medication Taper Regimen Time frame to taper off 30-60 days Medication to taper Taper Regimen Comments Methadone Taper by no more than 25% Morphine Taper by no more than 25% Tramadol Taper by no more

More information

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid

More information

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract

More information

Basic Medication Administration Exam RN (BMAE-RN) Study Guide

Basic Medication Administration Exam RN (BMAE-RN) Study Guide Basic Medication Administration Exam RN (BMAE-RN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM, subcut injections

More information

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: Frenchay 0117 340 6692 Southmead 0117 323

More information

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction June 9, 2011 Tufts Health Care Institute Program on Opioid Risk Management Daniel

More information

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES

SAFE PAIN MEDICATION PRESCRIBING GUIDELINES Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses

More information

Thinking Outside the Box for the Treatment of Cancer Pain

Thinking Outside the Box for the Treatment of Cancer Pain Thinking Outside the Box for the Treatment of Cancer Pain Suzette Walker, MSN, FNP-C, AOCNP DNPc Co-Director Symptom Management & Supportive Care Program University of Michigan Comprehensive Cancer Center

More information

Reducing harm from high-alert medications

Reducing harm from high-alert medications Institute for Healthcare Improvement s 5 Million Lives Campaign Best-practice protocols: Reducing harm from high-alert medications The Institute for Healthcare Improvement challenges clinicians and administrators

More information

How To Treat An Alcoholic Patient

How To Treat An Alcoholic Patient Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 Discontinue all lorazepam

More information

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS Update in Anaesthesia Acute pain management for opioid tolerant patients Simon Marshall and Mark Jackson* *Correspondence email: mark.jackson@rdeft.nhs.uk INTRODUCTION Opioid tolerance is usually encountered

More information

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth I. II. Background A. AWS can occur in anyone who consumes alcohol B. Risk correlates

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

Welcome to the Internal Medicine Intern Teaching Course

Welcome to the Internal Medicine Intern Teaching Course Welcome to the Internal Medicine Intern Teaching Course Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care mhagman@u.washington.edu pager 206-540-9725 Intern Teaching

More information

General PROVIDER INITIALS: PHYSICIAN ORDERS

General PROVIDER INITIALS: PHYSICIAN ORDERS Height Weight Allergies If appropriate for patient condition, please consider the following order sets: Initiate Electrolyte Replcement: Med/Surg, Med/Surg Tele Physician Order #842 General Vital Signs

More information

Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal

Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Kirsten H. Ohler, Pharm.D., BCPS Clinical Assistant Professor Neonatal / Pediatric Clinical Pharmacist University of Illinois at

More information

October 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,

October 2012. We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, October 2012 he Knowledge and Attitudes Survey Regarding Pain tool can be used to assess nurses and other professionals in your setting and as a pre and post test evaluation measure for educational programs.

More information

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC

SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC SELECTED OPIATES TOXICITY A MODERN DAY EPIDEMIC Learning Objectives: 1. Identify the names and reasons/circumstances for additional toxicity of SELECTED OPIATES hydromorphone DILAUDID Methadone Fentanyl/DURAGESIC

More information

Opioid toxicity and alternative opioids. Palliative care fixed resource session

Opioid toxicity and alternative opioids. Palliative care fixed resource session Opioid toxicity and alternative opioids Palliative care fixed resource session Opioid toxicity and alternative opioids - aims Know the symptoms of opioid toxicity Understand which patients are at higher

More information

Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015

Best Practices for Patients With Pain. Commonly Used Over the Counter (OTC) Pain Relievers 5/15/2015 Faculty Best Practices for Patients With Pain Nancy Bishop, RPh Assistant State Pharmacy Director Alabama Department of Public Health Satellite Conference and Live Webcast Wednesday, May 20, 2015 2:00

More information

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder

More information

Post-operative Pain Management

Post-operative Pain Management Post-operative Pain Management Total Hip Replacement www.ormc.org A member of the Greater Hudson Valley Health System Post-operative Pain MANAGEMENT Post-operative pain management after total joint replacement

More information

The Outpatient Knee Replacement Program at Orlando Orthopaedic Center. Jeffrey P. Rosen, MD

The Outpatient Knee Replacement Program at Orlando Orthopaedic Center. Jeffrey P. Rosen, MD The Outpatient Knee Replacement Program at Orlando Orthopaedic Center Jeffrey P. Rosen, MD Anesthesia Pain Management Post-Op / Discharge Protocols The Orlando Orthopaedic Center Joint Replacement Team

More information

Magee-Womens Hospital

Magee-Womens Hospital Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie

More information

26. ACUTE PAIN MANAGEMENT IN THE FIELD

26. ACUTE PAIN MANAGEMENT IN THE FIELD . ACUTE PAIN MAGEMENT IN THE FIELD INTRODUCTION The management of pain in an austere environment depends on trained personnel who are motivated to aggressively treat acute pain. Efforts to improve perioperative

More information

Welcome to the Internal Medicine Intern Teaching Conference Series

Welcome to the Internal Medicine Intern Teaching Conference Series Welcome to the Internal Medicine Intern Teaching Conference Series Melissa (Moe) Hagman, MD, FACP University of Washington Internal Medicine & Palliative Care mhagman@uw.edu pager 206-540-9725 Intern Teaching

More information

Weaning off your pain medicine

Weaning off your pain medicine Weaning off your pain medicine UHN Information for patients taking opioid pain medicines Read this booklet to learn about: why you need to wean off your pain medicine how to wean off slowly how to control

More information

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide Review correct procedure and precautions for the following routes of administration: Ear drops Enteral feeding tube Eye drops IM,

More information

Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION

Pain Management Case Studies. Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION Pain Management Case Studies Adapted from: IMPROVING END-OF-LIFE CARE A RESOURCE GUIDE FOR PHYSICIAN EDUCATION 3rd Edition David E. Weissman, MD Director, Palliative Care Program Medical College of Wisconsin

More information

9/16/2010. Contact Information. Objectives. Analgesic Ketamine (Ketalar )

9/16/2010. Contact Information. Objectives. Analgesic Ketamine (Ketalar ) Analgesic Ketamine (Ketalar )..the long and winding road to clinical practice Contact Information Lois Pizzi BSN, RN-BC Inpatient Pain Management Clinician UPMC Presbyterian Shadyside pizzilj@upmc.edu

More information

7. In applying the principles of pain treatment, what is the first consideration?

7. In applying the principles of pain treatment, what is the first consideration? CHAPTER 1 PAIN 1. A chronic pain client reports to you, the charge nurse, that the nurse have not been responding to requests for pain medication. What is your initial action? a. Check the MARs and nurses

More information

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid? Opioid Addiction & Methadone Maintenance Treatment Dr. Nick Wong MD, CCFP AADAC Edmonton ODP AADAC AHMB Concurrent Disorder Series September 13, 2007 1 What is Methadone? What is methadone? Synthetic opioid.

More information

END OF LIFE MEDICINES INFORMATION PACK

END OF LIFE MEDICINES INFORMATION PACK END OF LIFE MEDICINES INFORMATION PACK Advice on end of life medication is available from the nursing and medical team at St Nicholas Hospice Care - telephone 01284 766133. Many drugs used in palliative

More information

Goals! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Addiction Vs! Dependence! The best laid If a tree falls!

Goals! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Addiction Vs! Dependence! The best laid If a tree falls! Goals! Screening for Addiction and Dependence! Compassionate and Appropriate Use of Narcotics in Addiction! David Martorano, M.D.! Implementing a Pain Contract! Narcotics & Pain Management in Addiction!

More information

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients Jennifer Kuhns, Pharm.D. Pharmacy Practice Resident Children s Hospital of Michigan **The speaker has no actual or potential

More information

Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010

Pain Management. Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Mehraneh Khalighi, MD Original Date/Last Reviewed: January 2009/March 2010 Pain Management Learning Objectives- Identify most common barriers to effective treatment of pain. Describe principles of effective

More information

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse J E F F R E I T E R, P H D, A B P P H E A L T H P O I N T C O M M U N I T Y H E A L T H C E N T E R S S P R I N G 2 0 1 3 A

More information

Narcotic drugs used for pain treatment Version 4.3

Narcotic drugs used for pain treatment Version 4.3 Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the

More information

Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient

Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient Sick, Sicker, Sickest: Anesthesia in the Critically Ill Patient Kim Spelts, CVT, VTS (Anesthesia), CCRP, CCMT Peak Performance Veterinary Group No anesthetic procedure is entirely safe, but critically

More information

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist

Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids

More information

NEW PATIENTS' INFORMATION SHEET

NEW PATIENTS' INFORMATION SHEET NEW PATIENTS' INFORMATION SHEET Please print clearly. Please complete all information so that your claim can be processed quickly and efficiently. Thank you! PATIENT INFORMATION (First) (MI) (Last) Name

More information

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE

DISCHARGE CRITERIA FOR PHASE I & II- POST ANESTHESIA CARE REFERENCES: The Joint Commission Accreditation Manual for Hospitals American Society of Post Anesthesia Nurses: Standards of Post Anesthesia Nursing Practice (1991, 2002). RELATED DOCUMENTS: SHC Administrative

More information

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY

PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY AN EXAMINATION OF KNOWLEDGE IN: PALLIATIVE CARE PAIN MANAGEMENT AND NON-PAIN SYMPTOMS ONLY (EPERC TEST #1) 40 QUESTIONS; MULTIPLE CHOICE; SINGLE-BEST ANSWER Supplied by: End of Life Physician Education

More information

UNIT VIII NARCOTIC ANALGESIA

UNIT VIII NARCOTIC ANALGESIA UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and

More information

Care Guide: Cancer Pain

Care Guide: Cancer Pain Care Guide: Cancer Pain Key Points: Cancer Pain Specific Pain Problems 1. Pain is defined as an independent and emotional experience associated with actual or potential tissue damage or described in terms

More information

How to take your Opioid Pain Medication

How to take your Opioid Pain Medication How to take your Opioid Pain Medication Today your doctor gave you a prescription for medication to help relieve your pain. The pain medication is called an opioid or narcotic. Taking pain medication,

More information

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief

Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu. Barriers to effective pain relief Lora McGuire MS, RN Educator and Consultant lmcguire@jjc.edu Barriers to effective pain relief Freedom from pain is a basic human right -WHO Pain is whatever the experiencing person says it is and exists

More information

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal

Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal Use of opioids in Patients with Impaired Renal Function Dr Jane Neerkin, Dr Mary Brennan, Dr Humeira Jamal Great care is required when prescribing opioids to patients with impaired renal function. Many

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and

More information

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program

The TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential

More information

Chronic Pain in CKD. Sara N. Davison Frank Brennan Holly Koncicki

Chronic Pain in CKD. Sara N. Davison Frank Brennan Holly Koncicki Chronic Pain in CKD Sara N. Davison Frank Brennan Holly Koncicki Scoping Review: Pain in CKD Total number records identified for title and abstract review N = 997 Pain assessment and screening Epidemiology:

More information

Pain management. The WHO analgesic ladder

Pain management. The WHO analgesic ladder Pain management Successful treatment requires an accurate diagnosis of the cause and a rational approach to therapy. Most pains arise by stimulation of nociceptive nerve endings; the characteristics may

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

Cancer Pain. What is Pain?

Cancer Pain. What is Pain? Cancer Pain What is Pain? The International Association for the Study of Pain says that pain is "an unpleasant sensory and emotional experience associated with actual or potential tissue damage." Pain

More information

SUR COLON Colo-Rectal POST OP ADULT [3043020758] Version: 18-Sep-2013 (3043020758)

SUR COLON Colo-Rectal POST OP ADULT [3043020758] Version: 18-Sep-2013 (3043020758) SUR COLON Colo-Rectal POST OP ADULT [3043020758] Version: 18-Sep-2013 (3043020758) PATIENT CARE Admission [30430200010003] Admit to Inpatient [ADT1] Admitting Physician: Level of Care: Diagnosis/Reason

More information

Medical Coverage Policy Monitored Anesthesia Care (MAC)

Medical Coverage Policy Monitored Anesthesia Care (MAC) Medical Coverage Policy Monitored Anesthesia Care (MAC) Device/Equipment Drug Medical Surgery Test Other Effective Date: 9/1/2004 Policy Last Updated: 1/8/2013 Prospective review is recommended/required.

More information

Hospice & Palliative Care in Developing Countries

Hospice & Palliative Care in Developing Countries Hospice & Palliative Care in Developing Countries Compounding End of Life Medications WHO Recommendations to Developing Countries Russ Zakarian, Pharm.D. FASCP What is Compounding? Compounding is the method

More information

Blueprint for Prescriber Continuing Education Program

Blueprint for Prescriber Continuing Education Program CDER Final 10/25/11 Blueprint for Prescriber Continuing Education Program I. Introduction: Why Prescriber Education is Important Health care professionals who prescribe extended-release (ER) and long-acting

More information

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu

More information

Federal and State Laws Relating to Prescribing of Controlled Substances

Federal and State Laws Relating to Prescribing of Controlled Substances Federal and State Laws Relating to Prescribing of Controlled Substances Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine

More information

Paramedic Pediatric Medical Math Test

Paramedic Pediatric Medical Math Test Paramedic Pediatric Medical Math Test Name: Date: Problem 1 Your 4 year old pediatric patient weighs 40 pounds. She is febrile. You need to administer acetaminophen (Tylenol) 15mg/kg. How many mg will

More information

CHILDREN S SERVICES. Neonatal Abstinence Syndrome

CHILDREN S SERVICES. Neonatal Abstinence Syndrome CHILDREN S SERVICES Neonatal Abstinence Syndrome Background Neonatal Abstinence Syndrome (NAS) is a combination of behavioural and physiological signs and symptoms that occur in newborns going through

More information

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

MODERATE SEDATION RECORD (formerly termed Conscious Sedation) (POLICY #DOC-051) Page 1 of 6 WELLSPAN HEALTH - YORK HOSPITAL NURSING POLICY AND PROCEDURE Dates: Original Issue: September 1998 Annual Review: March 2012 Revised: March 2010 Submitted by: Brenda Artz

More information

VA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA

VA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM 118-28 SAN DIEGO, CA GUIDELINES FOR PATIENT-CONTROLLED ANALGESIA (PCA) AND PATIENT- CONTROLLED EPIDURAL ANALGESIA (PCEA) FOR ACUTE PAIN MANAGEMENT 1. PURPOSE: To assure the safe and effective use of patient controlled analgesia

More information